IGC Pharma (IGC) Free Cash Flow (QoQ) (2010 - 2025)
IGC Pharma (IGC) Free Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-49.75% |
| Jun 30, 2025 |
-89.17% |
| Mar 31, 2025 |
44.35% |
| Dec 31, 2024 |
-31.12% |
| Sep 30, 2024 |
42.74% |
| Jun 30, 2024 |
-230.87% |
| Mar 31, 2024 |
67.31% |
| Dec 31, 2023 |
-0.12% |
| Sep 30, 2023 |
-11.09% |
| Jun 30, 2023 |
2.23% |
| Mar 31, 2023 |
31.75% |
| Dec 31, 2022 |
-73.95% |
| Sep 30, 2022 |
44.81% |
| Jun 30, 2022 |
-139.24% |
| Mar 31, 2022 |
60.35% |
| Dec 31, 2021 |
-4.93% |
| Sep 30, 2021 |
-20.06% |
| Jun 30, 2021 |
25.06% |
| Mar 31, 2021 |
-29.89% |
| Dec 31, 2020 |
27.30% |
